DUBLIN -- (BUSINESS WIRE) -- Research and Markets (http://www.researchandmarkets.com/research/7pb2q9/sensory_organ) has announced the addition of the "Sensory Organ Partnering Terms and Agreements" report to their offering.
The Sensory Organ Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter sensory organ partnering deals. The majority of deals are discovery, preclinical or development stage whereby the licensee obtains a right or an option right to license the licensors sensory organ technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
The report includes an analysis of financial deal terms by stage at signing covering headline value, upfront payment, milestone payments and royalty rates. The initial chapters of this report provide an orientation of sensory organ dealmaking and business activities. Chapter 1 provides an introduction to the report.
Chapter 2 provides an overview of the trends in sensory organ dealmaking since 2007 covering trends by year, deal type, stage of development, technology type and therapeutic indication. In addition the chapter includes an analysis of financial deal terms by stage at signing covering headline value, upfront payment, milestone payments and royalty rates. Analysis includes median values and distribution of values for each stage of development.
Chapter 3 provides a review of the leading sensory organ deals since 2007. Deals are listed by headline value, signed by bigpharma, most active bigpharma, and most active of all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
Chapter 4 provides a comprehensive listing of the top 50 bigpharma companies with a brief summary followed by a comprehensive listing of sensory organ deals, as well as contract documents available in the public domain. Where available, each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.
Chapter 5 provides comprehensive access to all sensory organ deals since 2007 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.
Chapter 6 provides a comprehensive directory of all sensory organ partnering deals signed and announced since 2007. The chapter is organized by specific sensory organ therapy focus. Each deal title links via Weblink to an online version of the deal record and, where available, the contract document, providing easy access to each contract document on demand.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of dermatology technologies and products.
- Baxter International
- Squibb C
- Eli Lilly
- Endo Pharmaceuticals
- Forest Laboratories
- Johnson & Johnson
- Merck & Co
- Merck KGaA
- Mitsubishi Tanabe
- Warner Chilcott
For more information visit http://www.researchandmarkets.com/research/7pb2q9/sensory_organ.
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.